glp 1 and parkinson's disease GLP-1 Agonists: A New Frontier in Parkinson’s Treatment? GLP-1/GIP dual agonist tirzepatide alleviates

Compounded drugs can be important for overcoming shortages or meeting unique patient needs but compounders should not try to compound drugs in a way that circumvents FDAs approval process. The 30 companies that received warning letters are mostly small to midsize, digital telehealth providers that moved quickly to meet surging consumer demand for GLP-1 weight loss therapies when manufacturing capacity constraints limited supplies

Wang EJ, Li Y, Lin M, et al

Think soybeans, chickpeas, flaxseeds and sesame seeds

And because it's drug-free, you're not creating dependency or risking side effects

Others have utilized its availability through compounding pharmacies due to shortages through conventional manufacturers and pharmacies